A Pharmacokinetics (PK) Study in Healthy Adults

NCT06911216 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

8

Enrollment

INDUSTRY

Sponsor class

Conditions

Blepharoptosis

Interventions

DRUG: STN1013800 ophthalmic solution

Sponsor

Santen Pharmaceutical Co., Ltd.